Vanda Pharmaceuticals Inc (LTS:0LKB)
$ 4.6993 -0.1396 (-2.88%) Market Cap: 281.05 Mil Enterprise Value: -87.28 Mil PE Ratio: 0 PB Ratio: 0.50 GF Score: 63/100

Q4 2019 Vanda Pharmaceuticals Inc Earnings Call Transcript

Feb 25, 2020 / 09:30PM GMT
Release Date Price: $17.32
Operator

Ladies and gentlemen, thank you for standing by, and welcome to the Vanda Pharmaceuticals Fourth Quarter 2019 Earnings Conference Call. (Operator Instructions) Please be advised that today's conference is being recorded. (Operator Instructions) I'd now like to hand the conference over to your speaker today, Mr. Kevin Moran, Vice President and Controller. Please go ahead, sir.

Aranthan Jones
Vanda Pharmaceuticals Inc. - Chief Corporate Affairs & Communications Officer

Good afternoon. This isn't Kevin. This is AJ Jones, Chief Corporate Affairs Officer. But thank you so much, Liz, for that setup. I do appreciate it. Good afternoon, everyone, and thank you for joining us to discuss Vanda Pharmaceuticals fourth quarter and full year 2019 performance. Our fourth quarter and full year 2019 results were released this afternoon and are available on SEC's EDGAR system and on our website, vandapharmaceuticals.com. In addition, we are providing live and archived versions of this conference call on our website.

Joining me today for this call is Dr. Mihales

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot